About this item:

122 Views | 82 Downloads

Author Notes:

Colleen F. Kelley, Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, The Hope Clinic, 500 Irvin Ct Suite 200, Decatur, GA 30030, USA. Tel: 404‐712‐1823. Email: colleen.kelley@emory.edu

CFK conceived the project, supervised all human subjects and laboratory research, verified all data and findings and wrote the manuscript. IP wrote the manuscript. RY performed laboratory assays, data analyses and provided critical review of the manuscript. ZZ performed data analyses, wrote and provided critical review of the manuscript. VEVD wrote and provided critical review of the manuscript. SG performed dual IHC‐staining experiments and provided critical review of the manuscript. RRA provided guidance on immunologic assays and interpretation and critical review of the manuscript. VF assisted with IHC data analyses and interpretation and provided critical review of the manuscript. CSK performed microbiome sequencing assays and provided critical review of the manuscript. TJBD analysed microbiome data and provided critical review of the manuscript. YH performed data analyses and provided critical review of the manuscript. CGA assisted with data analyses and provided critical review of the manuscript. PSS contributed to the construct and conduct of the human subjects cohort and provided critical review of the manuscript. RMB oversaw the development and application of the automated immunohistochemistry with quantitative image analysis protocols, assisted with interpretation of data and analyses, and provided critical review of the manuscript.

We sincerely thank our study volunteers for their participation in this research.

All authors report no competing interests with this work.

Subjects:

Research Funding:

The study received grants K23 AI108335 (CFK), U19 AI109633 (RRA.), The Emory Center for AIDS Research P30AI050409 and The Atlanta Clinical and Translational Science Institute UL1TR000454.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Immunology
  • Infectious Diseases
  • men who have sex with men
  • rectal mucosa
  • HIV transmission
  • receptive anal intercourse
  • mucosal immunology
  • microbiome
  • REGULATORY T-CELLS
  • ALPHA
  • TRANSMISSION
  • EXPRESSION
  • IL-17
  • RISK

Condomless receptive anal intercourse is associated with markers of mucosal inflammation in a cohort of men who have sex with men in Atlanta, Georgia

Show all authors Show less authors

Tools:

Journal Title:

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY

Volume:

Volume 24, Number 12

Publisher:

, Pages e25859-e25859

Type of Work:

Article | Final Publisher PDF

Abstract:

Introduction: We previously showed that the rectal mucosal immune environment among men who have sex with men (MSM) engaging in condomless receptive anal intercourse (CRAI) is immunologically distinct from that of men who do not engage in anal intercourse (AI). Here, we further examined these differences with quantitative immunohistochemistry to better understand the geographic distribution of immune markers of interest. Methods: We enrolled a cohort of MSM engaging in CRAI (n = 41) and men who do not engage in AI (n = 21) between October 2013 and April 2015. Participants were healthy, HIV-negative men aged 18–45 from the metro Atlanta area. We performed rectal mucosal sampling via rigid sigmoidoscopy during two study visits separated by a median of nine weeks and timed with sexual activity for MSM engaging in CRAI. We used standardized, automated immunohistochemistry and quantitative image analysis to investigate the rectal mucosal distribution of neutrophils (MPO), IL-17-producing cells (IL-17) and Tregs (FOXP3) in the lamina propria, and cellular proliferation (Ki67) and adherens junction protein (E-cadherin) in the epithelium. We examined associations between biomarker expression and the rectal mucosal microbiota composition by 16s rRNA sequencing. Results: Relative to the colonic crypt base, IL-17, FOXP3, and MPO expression increased towards the rectal lumen, while Ki67 decreased and E-cadherin was more uniformly distributed. Throughout the rectal mucosa distribution examined, MSM engaging in CRAI had higher mean lamina propria MPO expression (p = 0.04) and epithelial Ki67 (p = 0.04) compared to controls. There were no significant differences in IL-17, FOXP3 or E-cadherin expression. We found no significant associations of the five biomarkers with the global rectal microbiota composition or the individual taxa examined. Conclusions: Understanding the mucosal distribution of inflammatory mediators can enhance our knowledge of the earliest events in HIV transmission. Neutrophil enrichment and crypt epithelial cell proliferation likely represent sub-clinical inflammation in response to CRAI in the rectal mucosa of MSM, which could increase the risk for HIV acquisition. However, the contributory role of the microbiota in mucosal inflammation among MSM remains unclear. HIV prevention may be enhanced by interventions that reduce inflammation or capitalize on the presence of specific inflammatory mechanisms during HIV exposure.

Copyright information:

© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/rdf).
Export to EndNote